Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carboxylic Acid Activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114805177A details a green synthesis route for saxagliptin intermediates using di-tert-butyl dicarbonate, offering significant cost reduction in API manufacturing and scalable production.
Patent CN119638592A discloses a novel route for semaglutide side chain. Achieve high purity and reduced emulsification risks for scalable GLP-1 manufacturing.